Efficacy of Nitazoxanide against Cryptosporidium parvum in Cell Culture and in Animal Models

Nitazoxanide (NTZ), a drug currently being tested in human clinical trials for efficacy against chronic cryptosporidiosis, was assessed in cell culture and in two animal models. The inhibitory activity of NTZ was compared with that of paromomycin (PRM), a drug that is partially effective against Cry...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Theodos, Cynthia M., Griffiths, Jeffrey K., D’Onfro, Jennifer, Fairfield, Alexandra, Tzipori, Saul
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1998
Assuntos:	Experimental Therapeutics
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC105716/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9687390/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.42.8.1959
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!